The Allstate Co. (NYSE:ALL – Get Free Report) declared a quarterly dividend on Thursday, November 14th,RTT News reports. Stockholders of record on Friday, November 29th will be given a dividend of 0.92 per share by the insurance provider on Thursday, January 2nd. This represents a $3.68 annualized dividend and a dividend yield of 1.88%.
Allstate has increased its dividend payment by an average of 18.1% per year over the last three years and has raised its dividend annually for the last 14 consecutive years. Allstate has a payout ratio of 19.5% meaning its dividend is sufficiently covered by earnings. Analysts expect Allstate to earn $19.07 per share next year, which means the company should continue to be able to cover its $3.68 annual dividend with an expected future payout ratio of 19.3%.
Allstate Stock Down 0.7 %
NYSE ALL opened at $195.85 on Friday. Allstate has a 52 week low of $130.77 and a 52 week high of $201.00. The company has a quick ratio of 0.40, a current ratio of 0.40 and a debt-to-equity ratio of 0.43. The business’s fifty day simple moving average is $189.58 and its 200-day simple moving average is $176.40. The firm has a market cap of $51.86 billion, a PE ratio of 12.68, a P/E/G ratio of 1.77 and a beta of 0.48.
Insider Transactions at Allstate
In related news, insider John E. Dugenske sold 36,367 shares of the company’s stock in a transaction that occurred on Friday, September 20th. The stock was sold at an average price of $191.38, for a total value of $6,959,916.46. Following the completion of the transaction, the insider now directly owns 27,364 shares of the company’s stock, valued at $5,236,922.32. This represents a 57.06 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, CEO Thomas J. Wilson sold 90,000 shares of the company’s stock in a transaction that occurred on Wednesday, August 21st. The shares were sold at an average price of $179.34, for a total value of $16,140,600.00. Following the completion of the transaction, the chief executive officer now directly owns 88,552 shares of the company’s stock, valued at $15,880,915.68. This trade represents a 50.41 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 143,049 shares of company stock valued at $26,106,112. 1.80% of the stock is currently owned by corporate insiders.
Analysts Set New Price Targets
ALL has been the topic of several research analyst reports. The Goldman Sachs Group boosted their price objective on shares of Allstate from $199.00 to $204.00 and gave the company a “buy” rating in a report on Thursday, August 15th. Wells Fargo & Company boosted their price objective on shares of Allstate from $175.00 to $186.00 and gave the company an “equal weight” rating in a report on Tuesday, November 5th. UBS Group boosted their price target on shares of Allstate from $216.00 to $225.00 and gave the stock a “buy” rating in a research note on Monday, November 4th. Piper Sandler boosted their price target on shares of Allstate from $188.00 to $196.00 and gave the stock an “overweight” rating in a research note on Friday, August 16th. Finally, Evercore ISI boosted their price target on shares of Allstate from $191.00 to $195.00 and gave the stock an “in-line” rating in a research note on Wednesday, October 9th. One research analyst has rated the stock with a sell rating, two have issued a hold rating, thirteen have assigned a buy rating and one has assigned a strong buy rating to the company. According to data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and an average price target of $212.56.
Check Out Our Latest Report on ALL
Allstate Company Profile
The Allstate Corporation, together with its subsidiaries, provides property and casualty, and other insurance products in the United States and Canada. It operates in five segments: Allstate Protection; Protection Services; Allstate Health and Benefits; Run-off Property-Liability; and Corporate and Other segments.
Featured Articles
- Five stocks we like better than Allstate
- Health Care Stocks Explained: Why You Might Want to Invest
- Cisco Systems Long-Term AI Play Turns a Corner: New Highs Likely
- How Technical Indicators Can Help You Find Oversold StocksĀ
- Why Zscaler Stock Has Analysts So Excited
- How to Invest in Biotech Stocks
- Spotify Stock Surge: Why Investors Are Buying Despite High Prices
Receive News & Ratings for Allstate Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Allstate and related companies with MarketBeat.com's FREE daily email newsletter.